ERIC WORKSHOP AT THE EHA-ISHBT HEMATOLOGY TUTORIAL 2020
27 FEBRUARY, 2020 (CHANDIGARH, INDIA)

• ERIC Agenda
• Chl+ Obinutuzumab in first line: a study outside clinical trials– Y. Herishanu
• Final analysis of the BTK mutation project – L. Scarfò
• Update on the certification and recertification process – S. Pavlova

49th GENERAL ASSEMBLY OF ERIC MEMBERS AT EHA 2020 – VIRTUAL MEETING
11 JUNE, 2020 (VIRTUAL, ZOOM)

• AGENDA

• Welcome and Introduction – Paolo Ghia
• Other malignancies in CLL – Michael Doubek
• Complex karyotype and novel agents – Panagiotis Baliakas
• The ERIC database has been launched, an update – Eva Minga
• Prognostic and predictive impact of TP53 variants below 10% VAF – Sarka Pavlova & Sarka Pospisilova
• The CLL patient empowerment program an update – Christina Karamanidou

II ERIC INTERNATIONAL MEETING – NEW FRONTIERS IN CLL RESEARCH
1-3 OCTOBER, 2020  (VIRTUAL)

• Agenda

IG WORKSHOP BY ERIC & THE TURKISH SOCIETY OF HEMATOLOGY
24-25 OCTOBER, 2020  (VIRTUAL)

Read more

MRD IN CLL WORKSHOP IN TAIWAN
7 NOVEMBER, 2020  (VIRTUAL)

• Agenda
• Treatment landscape of CLL & Role of MRD in CLL_Paolo Ghia
• Introduction of MRD in CLL- Flow & NGS_Andy Rawstron